Cargando…

Pseudotyping of VSV with Ebola virus glycoprotein is superior to HIV-1 for the assessment of neutralising antibodies

Ebola virus (EBOV) is an enveloped, single-stranded RNA virus that can cause Ebola virus disease (EVD). It is thought that EVD survivors are protected against subsequent infection with EBOV and that neutralising antibodies to the viral surface glycoprotein (GP) are potential correlates of protection...

Descripción completa

Detalles Bibliográficos
Autores principales:	Steeds, Kimberley, Hall, Yper, Slack, Gillian S., Longet, Stephanie, Strecker, Thomas, Fehling, Sarah Katharina, Wright, Edward, Bore, Joseph Akoi, Koundouno, Fara Raymond, Konde, Mandy Kader, Hewson, Roger, Hiscox, Julian A., Pollakis, Georgios, Carroll, Miles W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7459353/ https://www.ncbi.nlm.nih.gov/pubmed/32868837 http://dx.doi.org/10.1038/s41598-020-71225-1

Ejemplares similares

Complement-Mediated Neutralisation Identified in Ebola Virus Disease Survivor Plasma: Implications for Protection and Pathogenesis
por: Mellors, Jack, et al.
Publicado: (2022)

Influence of Landscape Patterns on Exposure to Lassa Fever Virus, Guinea
por: Longet, Stephanie, et al.
Publicado: (2023)

Human Diversity of Killer Cell Immunoglobulin-Like Receptors and Human Leukocyte Antigen Class I Alleles and Ebola Virus Disease Outcomes
por: Wawina-Bokalanga, Tony, et al.
Publicado: (2021)

Longitudinal antibody and T cell responses in Ebola virus disease survivors and contacts: an observational cohort study
por: Thom, Ruth, et al.
Publicado: (2020)

Efficient generation of vesicular stomatitis virus (VSV)-pseudotypes bearing morbilliviral glycoproteins and their use in quantifying virus neutralising antibodies
por: Logan, Nicola, et al.
Publicado: (2016)

Early transmission and case fatality of Ebola virus at the index site of the 2013–16 west African Ebola outbreak: a cross-sectional seroprevalence survey
por: Timothy, Joseph W S, et al.
Publicado: (2019)

Cross-Neutralisation of Novel Bombali Virus by Ebola Virus Antibodies and Convalescent Plasma Using an Optimised Pseudotype-Based Neutralisation Assay
por: Bentley, Emma M., et al.
Publicado: (2021)

Cell- Cell Transmission of VSV-G Pseudotyped Lentivector Particles
por: Skinner, Amy M., et al.
Publicado: (2013)

Detectable Vesicular Stomatitis Virus (VSV)–Specific Humoral and Cellular Immune Responses Following VSV–Ebola Virus Vaccination in Humans
por: Poetsch, Joseph H, et al.
Publicado: (2019)

Characterisation of SARS-CoV-2 Lentiviral Pseudotypes and Correlation between Pseudotype-Based Neutralisation Assays and Live Virus-Based Micro Neutralisation Assays
por: Hyseni, Inesa, et al.
Publicado: (2020)

Analyses of Entry Mechanisms of Novel Emerging Viruses Using Pseudotype VSV System
por: Tani, Hideki
Publicado: (2014)

Enhanced immunosurveillance for animal morbilliviruses using vesicular stomatitis virus (VSV) pseudotypes
por: Logan, Nicola, et al.
Publicado: (2016)

Analysis of VSV pseudotype virus infection mediated by rubella virus envelope proteins
por: Sakata, Masafumi, et al.
Publicado: (2017)

VSV-G pseudotyping rescues HIV-1 CA mutations that impair core assembly or stability
por: Brun, Sonia, et al.
Publicado: (2008)

Postexposure Prophylaxis With rVSV-ZEBOV Following Exposure to a Patient With Ebola Virus Disease Relapse in the United Kingdom: An Operational, Safety, and Immunogenicity Report
por: Davis, Chris, et al.
Publicado: (2019)

Evaluation of a Pseudotyped Virus Neutralisation Test for the Measurement of Equine Influenza Virus-Neutralising Antibody Responses Induced by Vaccination and Infection
por: Kinsley, Rebecca, et al.
Publicado: (2020)

Humoral and cellular immune response induced by rVSVΔG-ZEBOV-GP vaccine among frontline workers during the 2013–2016 West Africa Ebola outbreak in Guinea
por: Boum, Yap, et al.
Publicado: (2020)

Human Transcriptomic Response to the VSV-Vectored Ebola Vaccine
por: Santoro, Francesco, et al.
Publicado: (2021)

The Response to and Impact of the Ebola Epidemic: Towards an Agenda for Interdisciplinary Research
por: Calnan, Michael, et al.
Publicado: (2017)

Expanding the Arterivirus Host Spectrum: Olivier’s Shrew Virus 1, A Novel Arterivirus Discovered in African Giant Shrews
por: Vanmechelen, Bert, et al.
Publicado: (2018)

Effective in vivo and ex vivo gene transfer to intestinal mucosa by VSV-G-pseudotyped lentiviral vectors
por: Matsumoto, Hiroshi, et al.
Publicado: (2010)

Avatar Mice Underscore the Role of the T Cell-Dendritic Cell Crosstalk in Ebola Virus Disease and Reveal Mechanisms of Protection in Survivors
por: Rottstegge, Monika, et al.
Publicado: (2022)

A robust lentiviral pseudotype neutralisation assay for in-field serosurveillance of rabies and lyssaviruses in Africa
por: Wright, Edward, et al.
Publicado: (2009)

Safety of Recombinant VSV–Ebola Virus Vaccine Vector in Pigs
por: de Wit, Emmie, et al.
Publicado: (2015)

Ebola Virus Disease Survivors Show More Efficient Antibody Immunity than Vaccinees Despite Similar Levels of Circulating Immunoglobulins
por: Koch, Till, et al.
Publicado: (2020)

Dilemmas in Managing Pregnant Women With Ebola: 2 Case Reports
por: Caluwaerts, Séverine, et al.
Publicado: (2016)

Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!)
por: Henao-Restrepo, Ana Maria, et al.
Publicado: (2017)

Induction of Broadly Neutralising HCV Antibodies in Mice by Integration-Deficient Lentiviral Vector-Based Pseudotyped Particles
por: Deng, Yao, et al.
Publicado: (2013)

Cholesterol supplementation during production increases the infectivity of retroviral and lentiviral vectors pseudotyped with the vesicular stomatitis virus glycoprotein (VSV-G)
por: Chen, Yong, et al.
Publicado: (2009)

Characterisation of the T-cell response to Ebola virus glycoprotein amongst survivors of the 2013–16 West Africa epidemic
por: Tipton, T. R. W., et al.
Publicado: (2021)

Correlation between pseudotyped virus and authentic virus neutralisation assays, a systematic review and meta-analysis of the literature
por: Cantoni, Diego, et al.
Publicado: (2023)

rVSVΔG-ZEBOV-GP (also designated V920) recombinant vesicular stomatitis virus pseudotyped with Ebola Zaire Glycoprotein: Standardized template with key considerations for a risk/benefit assessment
por: Monath, Thomas P., et al.
Publicado: (2019)

Dose-Dependent Response to Infection with Ebola Virus in the Ferret Model and Evidence of Viral Evolution in the Eye
por: Watson, Robert J., et al.
Publicado: (2021)

Comparative analysis of the transduction efficiency of five adeno associated virus serotypes and VSV-G pseudotype lentiviral vector in lung cancer cells
por: Chen, Chiachen, et al.
Publicado: (2013)

Filovirus Neutralising Antibodies: Mechanisms of Action and Therapeutic Application
por: Hargreaves, Alexander, et al.
Publicado: (2021)

Field Evaluation of Capillary Blood Samples as a Collection Specimen for the Rapid Diagnosis of Ebola Virus Infection During an Outbreak Emergency
por: Strecker, Thomas, et al.
Publicado: (2015)

From discovery to delivery: public sector development of the rVSV-ZEBOV Ebola vaccine
por: Herder, Matthew, et al.
Publicado: (2020)

Safety and immunogenicity of rVSVΔG-ZEBOV-GP Ebola vaccine in adults and children in Lambaréné, Gabon: A phase I randomised trial
por: Agnandji, Selidji T., et al.
Publicado: (2017)

Deep Sequencing of RNA from Blood and Oral Swab Samples Reveals the Presence of Nucleic Acid from a Number of Pathogens in Patients with Acute Ebola Virus Disease and Is Consistent with Bacterial Translocation across the Gut
por: Carroll, Miles W., et al.
Publicado: (2017)

The characterization of multiple novel paramyxoviruses highlights the diverse nature of the subfamily Orthoparamyxovirinae
por: Vanmechelen, Bert, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ukotd826t6r5i32u43fascrp28